Loading organizations...
Loading organizations...
Pharmaceuticals focused on treating diabetic and peripheral neuropathies.
Regenacy Pharmaceuticals has raised $39.3M across 2 funding rounds.
Regenacy Pharmaceuticals has raised $39.3M in total across 2 funding rounds.
Regenacy Pharmaceuticals has raised $39.3M in total across 2 funding rounds.
Regenacy Pharmaceuticals's investors include Todd Kaloudis, 3E Bioventures Capital, Yonjin Capital, Marc Cohen, Frank Yan, Taya Ventures, Daguan Wang.
Regenacy Pharmaceuticals has raised $39.3M across 2 funding rounds. Most recently, it raised $9.3M Series B in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 24, 2022 | $9.3M Series B | Todd Kaloudis | 3E Bioventures Capital, Yonjin Capital |
| Mar 25, 2020 | $30.0M Series A | Marc Cohen | Frank Yan, Taya Ventures, Daguan Wang |